摘要
为建立稳定共表达乙型脑炎病毒(JEV)完整M前体蛋白(prM)和E蛋白的BHK-21细胞系,本研究在prM蛋白furin蛋白酶剪切位点编码基因中引入突变,将突变后的prM基因克隆于质粒中构建重组表达质粒pCAG-JEV-prM(R89A)E。将重组质粒转染BHK-21细胞,转染48 h后细胞用含G418的选择性培养基选择培养,进一步经细胞克隆纯化制备表达剪切位点突变的JEV prM-E蛋白的稳定细胞系。经IFA和western blot鉴定表明,该细胞系能表达JEV prM与E蛋白,所表达的prM蛋白未发生剪切;细胞经多次传代后仍能够稳定地共表达prM与E蛋白。该细胞系的建立为研究prM蛋白剪切对JEV粒子形成的影响以及亚单位疫苗的制备奠定了基础。
In order to establish the BHK-21 cell lines stably co-expressing prM-E fusion protein of Japanese encephalitis virus (JEV) with a mutant furin site to disable the pre-peptide cleavage of prM, BHK-21 cells was transfected with the recombinant plasmid pCAG-JEV-prM(R89A)E, which was constructed by introducing a point mutation at the cleavage site of prM gene by PCR and cloned into eukaryotic vector pCAG-neo with E gene. Cells stably co-expressing prM-E fusion protein were selected in the present of G418 and identified by indirect immunofluorescence assay and western blot. In addition, the cells displaying high-level protein expression were purified through limiting dilution cloning. Eventfully, the results showed that the cell line was able to express the intact prM of prM-E fusion protein. The established cell line would provide a basis for further study the effect of the cleavage event on mature mechanism of JEV and the development of JEV subunit vaccine.
出处
《中国预防兽医学报》
CAS
CSCD
北大核心
2013年第3期189-192,201,共5页
Chinese Journal of Preventive Veterinary Medicine
基金
国家公益性行业(农业)科研专项(201203082)
中央级公益性科研院所基本科研业务费专项(ZGKJ201106)